{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T21:22:36Z","timestamp":1785792156463,"version":"3.56.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T00:00:00Z","timestamp":1567987200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T00:00:00Z","timestamp":1567987200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s11060-019-03280-2","type":"journal-article","created":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T04:02:36Z","timestamp":1568001756000},"page":"135-141","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Efficacy of Dabrafenib for three children with brainstem BRAFV600E positive ganglioglioma"],"prefix":"10.1007","volume":"145","author":[{"given":"Laflamme","family":"Philippe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kondyli","family":"Maria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aljared","family":"Tariq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miconiatis","family":"Sofia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saint-Martin","family":"Christine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farmer","family":"Jean-Pierre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy W.","family":"Dudley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perreault","family":"S\u00e9bastien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jabado","family":"Nada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9773-0995","authenticated-orcid":false,"given":"Larouche","family":"Val\u00e9rie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,9]]},"reference":[{"issue":"3","key":"3280_CR1","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1227\/NEU.0000000000000619","volume":"76","author":"RW Dudley","year":"2015","unstructured":"Dudley RW, Torok MR, Gallegos DR, Mulcahy-Levy JM, Hoffman LM, Liu AK et al (2015) Pediatric low-grade ganglioglioma: epidemiology, treatments, and outcome analysis on 348 children from the surveillance, epidemiology, and end results database. Neurosurgery 76(3):313\u2013319","journal-title":"Neurosurgery"},{"issue":"2","key":"3280_CR2","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s11060-014-1450-1","volume":"118","author":"AJ Lindsay","year":"2014","unstructured":"Lindsay AJ, Rush SZ, Fenton LZ (2014) Pediatric posterior fossa ganglioglioma: unique MRI features and correlation with BRAF V600E mutation status. J Neurooncol 118(2):395\u2013404","journal-title":"J Neurooncol"},{"issue":"6","key":"3280_CR3","doi-asserted-by":"publisher","first-page":"867","DOI":"10.3171\/jns.1993.79.6.0867","volume":"79","author":"FF Lang","year":"1993","unstructured":"Lang FF, Epstein FJ, Ransohoff J, Allen JC, Wisoff J, Abbott IR et al (1993) Central nervous system gangliogliomas. Part 2: clinical outcome. J Neurosurg 79(6):867\u2013873","journal-title":"J Neurosurg"},{"issue":"6","key":"3280_CR4","doi-asserted-by":"publisher","first-page":"859","DOI":"10.3171\/jns.1993.79.6.0859","volume":"79","author":"DC Miller","year":"1993","unstructured":"Miller DC, Lang FF, Epstein FJ (1993) Central nervous system gangliogliomas. Part 1: Pathology. J Neurosurg 79(6):859\u2013866","journal-title":"J Neurosurg"},{"issue":"2","key":"3280_CR5","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1023\/A:1019661528350","volume":"59","author":"SH Im","year":"2002","unstructured":"Im SH, Chung CK, Cho BK, Wang KC, Yu IK, Song IC et al (2002) Intracranial ganglioglioma: preoperative characteristics and oncologic outcome after surgery. J Neurooncol 59(2):173\u2013183","journal-title":"J Neurooncol"},{"issue":"5","key":"3280_CR6","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1097\/00006123-199805000-00049","volume":"42","author":"CS Rumana","year":"1998","unstructured":"Rumana CS, Valadka AB (1998) Radiation therapy and malignant degeneration of benign supratentorial gangliogliomas. Neurosurgery 42(5):1038\u20131043","journal-title":"Neurosurgery"},{"issue":"4","key":"3280_CR7","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.ijrobp.2018.11.004","volume":"103","author":"JM Cherlow","year":"2019","unstructured":"Cherlow JM, Shaw DWW, Margraf LR, Bowers DC, Huang J, Fouladi M et al (2019) Conformal radiation therapy for pediatric patients with low-grade glioma: results from the children's oncology group phase 2 study ACNS0221. Int J Radiat Oncol Biol Phys 103(4):861\u2013868","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"3280_CR8","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/bpa.12103","volume":"24","author":"AM Donson","year":"2014","unstructured":"Donson AM, Kleinschmidt-DeMasters BK, Aisner DL, Bemis LT, Birks DK, Levy JM et al (2014) Pediatric brainstem gangliogliomas show BRAF(V600E) mutation in a high percentage of cases. Brain Pathol 24(2):173\u2013183","journal-title":"Brain Pathol"},{"issue":"6892","key":"3280_CR9","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/nature00766","volume":"417","author":"H Davies","year":"2002","unstructured":"Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S et al (2002) Mutations of the BRAF gene in human cancer. Nature 417(6892):949\u2013954","journal-title":"Nature"},{"key":"3280_CR10","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ejca.2017.12.007","volume":"91","author":"S Valpione","year":"2018","unstructured":"Valpione S, Carlino MS, Mangana J, Mooradian MJ, McArthur G, Schadendorf D et al (2018) Rechallenge with BRAF-directed treatment in metastatic melanoma: a multi-institutional retrospective study. Eur J Cancer 91:116\u2013124","journal-title":"Eur J Cancer"},{"issue":"7","key":"3280_CR11","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1158\/2159-8290.CD-14-0049","volume":"4","author":"JM Levy","year":"2014","unstructured":"Levy JM, Thompson JC, Griesinger AM, Amani V, Donson AM, Birks DK et al (2014) Autophagy inhibition improves chemosensitivity in BRAF(V600E) brain tumors. Cancer Discov 4(7):773\u2013780","journal-title":"Cancer Discov"},{"issue":"5","key":"3280_CR12","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00401-014-1337-4","volume":"128","author":"D Bechet","year":"2014","unstructured":"Bechet D, Gielen GG, Korshunov A, Pfister SM, Rousso C, Faury D et al (2014) Specific detection of methionine 27 mutation in histone 3 variants (H3K27M) in fixed tissue from high-grade astrocytomas. Acta Neuropathol 128(5):733\u2013741","journal-title":"Acta Neuropathol"},{"issue":"10","key":"3280_CR13","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1007\/s00381-015-2832-1","volume":"31","author":"S Puget","year":"2015","unstructured":"Puget S, Beccaria K, Blauwblomme T, Roujeau T, James S, Grill J et al (2015) Biopsy in a series of 130 pediatric diffuse intrinsic Pontine gliomas. Childs Nerv Syst 31(10):1773\u20131780","journal-title":"Childs Nerv Syst"},{"issue":"6","key":"3280_CR14","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00401-013-1120-y","volume":"125","author":"S Dahiya","year":"2013","unstructured":"Dahiya S, Haydon DH, Alvarado D, Gurnett CA, Gutmann DH, Leonard JR (2013) BRAF(V600E) mutation is a negative prognosticator in pediatric ganglioglioma. Acta Neuropathol 125(6):901\u2013910","journal-title":"Acta Neuropathol"},{"issue":"3","key":"3280_CR15","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s11060-016-2131-z","volume":"128","author":"CC Pan","year":"2016","unstructured":"Pan CC, Chen X, Xu C, Wu WH, Zhang P, Wang Y et al (2016) Brainstem gangliogliomas: prognostic factors, surgical indications and functional outcomes. J Neurooncol 128(3):445\u2013453","journal-title":"J Neurooncol"},{"issue":"10","key":"3280_CR16","doi-asserted-by":"publisher","first-page":"e159","DOI":"10.1200\/JCO.2012.44.1568","volume":"31","author":"S Rush","year":"2013","unstructured":"Rush S, Foreman N, Liu A (2013) Brainstem ganglioglioma successfully treated with vemurafenib. J Clin Oncol 31(10):e159\u2013e160","journal-title":"J Clin Oncol"},{"issue":"29","key":"3280_CR17","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1200\/JCO.2013.48.6852","volume":"32","author":"KC Shih","year":"2014","unstructured":"Shih KC, Shastry M, Williams JT, Jelsma PF, Abram SR, Ayyanar K et al (2014) Successful treatment with dabrafenib (GSK2118436) in a patient with ganglioglioma. J Clin Oncol 32(29):e98\u2013e100","journal-title":"J Clin Oncol"},{"issue":"2","key":"3280_CR18","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s11060-013-1176-5","volume":"114","author":"MC Chamberlain","year":"2013","unstructured":"Chamberlain MC (2013) Salvage therapy with BRAF inhibitors for recurrent pleomorphic xanthoastrocytoma: a retrospective case series. J Neurooncol 114(2):237\u2013240","journal-title":"J Neurooncol"},{"key":"3280_CR19","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/1471-2407-14-258","volume":"14","author":"GW Robinson","year":"2014","unstructured":"Robinson GW, Orr BA, Gajjar A (2014) Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy. BMC Cancer 14:258","journal-title":"BMC Cancer"},{"issue":"6","key":"3280_CR20","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1002\/pbc.24891","volume":"61","author":"F Bautista","year":"2014","unstructured":"Bautista F, Paci A, Minard-Colin V, Dufour C, Grill J, Lacroix L et al (2014) Vemurafenib in pediatric patients with BRAFV600E mutated high-grade gliomas. Pediatr Blood Cancer 61(6):1101\u20131103","journal-title":"Pediatr Blood Cancer"},{"issue":"11","key":"3280_CR21","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.6004\/jnccn.2016.0145","volume":"14","author":"SK Meletath","year":"2016","unstructured":"Meletath SK, Pavlick D, Brennan T, Hamilton R, Chmielecki J, Elvin JA et al (2016) Personalized treatment for a patient with a BRAF V600E mutation using Dabrafenib and a tumor treatment fields device in a high-grade glioma arising from ganglioglioma. J Natl Compr Canc Netw 14(11):1345\u20131350","journal-title":"J Natl Compr Canc Netw"},{"key":"3280_CR22","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1200\/JCO.2016.71.8726","volume":"35","author":"A Lassaletta","year":"2017","unstructured":"Lassaletta A, Zapotocky M, Mistry M et al (2017) Therapeutic and prognostic implications of BRAF V600E in pediatric low-grade gliomas. J Clin Oncol 35:2934\u20132941","journal-title":"J Clin Oncol"},{"issue":"1","key":"3280_CR23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2217\/cns-2016-0031","volume":"6","author":"NF Brown","year":"2017","unstructured":"Brown NF, Carter T, Mulholland P (2017) Dabrafenib in BRAFV600-mutated anaplastic pleomorphic xanthoastrocytoma. CNS Oncol 6(1):5\u20139","journal-title":"CNS Oncol"},{"issue":"11","key":"3280_CR24","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1002\/pbc.26086","volume":"63","author":"A Lassaletta","year":"2016","unstructured":"Lassaletta A, Guerreiro Stucklin A, Ramaswamy V, Zapotocky M, McKeown T, Hawkins C et al (2016) Profound clinical and radiological response to BRAF inhibition in a 2-month-old diencephalic child with hypothalamic\/chiasmatic glioma. Pediatr Blood Cancer 63(11):2038\u20132041","journal-title":"Pediatr Blood Cancer"},{"issue":"15_suppl","key":"3280_CR25","doi-asserted-by":"publisher","first-page":"10004","DOI":"10.1200\/jco.2015.33.15_suppl.10004","volume":"33","author":"MW Kieran","year":"2015","unstructured":"Kieran MW, Hargrave DR, Cohen KJ, Aerts I, Dunkel IJ, Hummel TR et al (2015) Phase 1 study of dabrafenib in pediatric patients (pts) with relapsed or refractory BRAF V600E high- and low-grade gliomas (HGG, LGG), Langerhans cell histiocytosis (LCH), and other solid tumors (OST). J Clin Oncol. 33(15_suppl):10004","journal-title":"J Clin Oncol."},{"issue":"3","key":"3280_CR26","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/bpa.12111","volume":"24","author":"C Koelsche","year":"2014","unstructured":"Koelsche C, Sahm F, Wohrer A, Jeibmann A, Schittenhelm J, Kohlhof P et al (2014) BRAF-mutated pleomorphic xanthoastrocytoma is associated with temporal location, reticulin fiber deposition and CD34 expression. Brain Pathol 24(3):221\u2013229","journal-title":"Brain Pathol"},{"issue":"5","key":"3280_CR27","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1097\/NEN.0000000000000188","volume":"74","author":"GF Reis","year":"2015","unstructured":"Reis GF, Pekmezci M, Hansen HM, Rice T, Marshall RE, Molinaro AM et al (2015) CDKN2A loss is associated with shortened overall survival in lower-grade (World Health Organization Grades II\u2013III) astrocytomas. J Neuropathol Exp Neurol 74(5):442\u2013452","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"3280_CR28","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/pbc.25787","volume":"63","author":"D Aguilera","year":"2016","unstructured":"Aguilera D, Janss A, Mazewski C, Castellino RC, Schniederjan M, Hayes L et al (2016) Successful retreatment of a child with a refractory brainstem ganglioglioma with vemurafenib. Pediatr Blood Cancer 63(3):541\u2013543","journal-title":"Pediatr Blood Cancer"},{"issue":"11","key":"3280_CR29","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/pbc.25084","volume":"61","author":"M Skrypek","year":"2014","unstructured":"Skrypek M, Foreman N, Guillaume D, Moertel C (2014) Pilomyxoid astrocytoma treated successfully with vemurafenib. Pediatr Blood Cancer 61(11):2099\u20132100","journal-title":"Pediatr Blood Cancer"},{"key":"3280_CR30","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/s12967-014-0356-1","volume":"12","author":"F del Bufalo","year":"2014","unstructured":"del Bufalo F, Carai A, Figa-Talamanca L, Pettorini B, Mallucci C, Giangaspero F et al (2014) Response of recurrent BRAFV600E mutated ganglioglioma to vemurafenib as single agent. J Transl Med 12:356","journal-title":"J Transl Med"},{"key":"3280_CR31","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1056\/NEJMoa1001671","volume":"363","author":"DA Krueger","year":"2010","unstructured":"Krueger DA, Care MM, Holland K et al (2010) Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis. N Engl J Med 363:1801\u20131811","journal-title":"N Engl J Med"}],"updated-by":[{"DOI":"10.1007\/s11060-019-03350-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T00:00:00Z","timestamp":1574640000000}}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-019-03280-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-019-03280-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-019-03280-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T23:06:21Z","timestamp":1599519981000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-019-03280-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,9]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["3280"],"URL":"https:\/\/doi.org\/10.1007\/s11060-019-03280-2","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s11060-019-03350-5","asserted-by":"object"}]},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,9]]},"assertion":[{"value":"20 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2019","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the original article, the author names were published incorrectly. The names are correct in this publication.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}